Semler Scientific reported a net income of $66.9 million for Q2 2025, a significant increase from $11,000 a year earlier. This surge was primarily attributed to an unrealized Bitcoin gain of $83.8 million, despite a 43% drop in revenue to $8.2 million and operating expenses climbing to $10.3 million. The company holds 5,021 Bitcoins valued at $586.2 million, having acquired 1,829 Bitcoins during the reporting period. Additionally, Semler launched CardioVanta, a new subsidiary targeting healthcare innovations for heart conditions.
"We have made excellent progress with our Bitcoin treasury strategy. Year-to-date through July 31, 2025, this strategy has generated more than $110.4 million in unrealized gains and delivered a 31.3% BTC yield."
"During the quarter, we were very pleased to launch CardioVanta, a wholly owned subsidiary that will drive our future healthcare initiatives focused on early detection of heart failure and cardiac arrhythmia."
Collection
[
|
...
]